There were no cures for degenerative disorders like Alzheimer's disease. A recent work in the UK offers
a way out. A hormone, Interleukin-1
(IL-1), thought to benefit head
injuries, is not benign. By administering a receptor antagonistic to IL-1,
the neurodegeneration was reduced.
We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.